Blog
RSS FeedPosted by Michael Wonder on 05 Sep 2023
Essential medicines lists are for high income countries too
5 September 2023 - On 26 July 2023, the World Health Organization published the 23rd edition of its essential medicines list.1 ...
Posted by Michael Wonder on 05 Sep 2023
‘Unacceptable’: Dad’s cancer treatment denied
6 September 2023 - Australians who can enlist radio stars and politicians are getting access to life saving cancer treatment while ...
Posted by Michael Wonder on 05 Sep 2023
Mum vows to keep pushing for fenfluramine PBS listing for Dravet syndrome, a severe form of epilepsy
5 September 2023 - Families calling for greater access to a medication that helps manage a severe form of epilepsy ...
Posted by Michael Wonder on 05 Sep 2023
Oncologists pen open letter to PHARMAC asking for more life-saving cancer drugs
5 September 2023 - Drug buying agency PHARMAC is not moving fast enough, says a gut cancer patient paying more ...
Posted by Michael Wonder on 04 Sep 2023
Working with Te Whatu Ora to enable better access to vaccines
4 September 2023 - This year, many New Zealanders received their vaccinations at pharmacies close to their homes or workplaces. ...
Posted by Michael Wonder on 04 Sep 2023
PHARMAC widens access to treatment for life-long bleeding disorder, severe haemophilia A
4 September 2023 - PHARMAC has confirmed it is widening access to emicizumab (Hemlibra) for the treatment of people with severe ...
Posted by Michael Wonder on 04 Sep 2023
ACT calls for "productivity focus" for PHARMAC
3 September 2023 - The policy was discussed on Q+A with Jack Tame by new candidate Todd Stephenson, who has ...
Posted by Michael Wonder on 04 Sep 2023
PHARMAC funds first treatment for primary progressive multiple sclerosis
4 September 2023 - PHARMAC has confirmed it is widening access to ocrelizumab (Ocrevus) as the first funded treatment for ...
Posted by Michael Wonder on 01 Sep 2023
Emergent BioSolutions’ Narcan nasal spray launches over the counter making it possible for everyone to help save a life from an opioid overdose emergency
30 August 2023 - Narcan nasal spray will be the first, life-saving emergency medicine for opioid overdose available on shelves beginning ...
Posted by Michael Wonder on 31 Aug 2023
New Zealand Pharmaceutical Schedule - 1 September 2023
1 September 2023 - The September 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Aug 2023
Schedule of Pharmaceutical Benefits - 1 September 2023
1 September 2023 - The September 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Aug 2023
Mitsubishi Tanabe Pharma Canada announces that company's oral treatment formulation for amyotrophic lateral sclerosis has been added to the provincial drug plans in New Brunswick and Nova Scotia
29 August 2023 - Mitsubishi Tanabe Pharma Canada today announced that Radicava oral suspension (edaravone) is now covered under the New ...
Posted by Michael Wonder on 27 Aug 2023
PHARMAC announcement of more blood cancer medicines welcomed
27 August 2023 - Myeloma New Zealand is welcoming Pharmac's announcement of more blood cancer medicines, but says the country is ...
Posted by Michael Wonder on 24 Aug 2023
PHARMAC seeking bids from suppliers for multiple myeloma treatments
24 August 2023 - PHARMAC is seeking bids from suppliers for two medicines, lenalidomide and pomalidomide, for use in the ...
Posted by Michael Wonder on 23 Aug 2023
PHARMAC confirms transition to a trastuzumab biosimilar and widens access to other types of cancer
23 August 2023 - PHARMAC is transitioning to a trastuzumab biosimilar, Herzuma, from the currently funded brand, Herceptin, as a result ...